Fluticasone Furoate Chemical Structure (Ff Vil Spl Graphic 01)
Fluticasone Furoate And Vilanterol Powder
Product Images NDC 66993-135
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 27 technical images submitted to the FDA as part of the official labeling for Fluticasone Furoate And Vilanterol (NDC 66993-135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Vilanterol Chemical Structure (Ff Vil Spl Graphic 02)
Figure 1 (Ff Vil Spl Graphic 03)
Figure 2 (Ff Vil Spl Graphic 04)
This appears to be a table showing interactions between two drugs - Ketoconazole and Verapamil. The table includes a "Fold Change" column, and some percentages and values but it is not clear what they refer to. The table also includes the recommendation to exercise caution and to not adjust the dose without consulting a healthcare provider.*
Figure 3 (Ff Vil Spl Graphic 05)
Figure 3 (Ff Vil Spl Graphic 06)
Figure 4 Day 1 (Ff Vil Spl Graphic 07)
Figure 4 Day 168 (Ff Vil Spl Graphic 08)
Not available. It appears to be an incomplete chart or graph.*
Figure 5 Day 1 (Ff Vil Spl Graphic 09)
Not available.*
Figure 5 Day 28 (Ff Vil Spl Graphic 10)
Figure 6 (Ff Vil Spl Graphic 11)
Figure 7 (Ff Vil Spl Graphic 12)
This appears to be a graph showing the LS Mean Change from Baseline in milliliters over time since dose in hours for three different treatments: Fluticasone furoate/vilanterol 100mcg/25mcg, Fluticasone furoate/vilanterol 200mcg/25mcg, and Fluticasone furoate 100mcg using ELLIPTA.*
Fluticasone Furoate/vilanterol Ellipta Inhaler (Ff Vil Spl Graphic 13)
Figure A (Ff Vil Spl Graphic 14)
Figure B (Ff Vil Spl Graphic 15)
Figure C (Ff Vil Spl Graphic 16)
Figure D (Ff Vil Spl Graphic 17)
Figure E (Ff Vil Spl Graphic 18)
Figure F (Ff Vil Spl Graphic 19)
Figure G (Ff Vil Spl Graphic 20)
This text is a warning message advising against blocking the air vent with one's fingers.*
Figure H (Ff Vil Spl Graphic 21)
Figure I (Ff Vil Spl Graphic 22)
Figure J (Ff Vil Spl Graphic 23)
Figure K (Ff Vil Spl Graphic 24)
Figure L (Ff Vil Spl Graphic 25)
Fluticasone Furoate-vilanterol Ellipta 100 Mcg-25mcg Carton (Ff Vil Spl Graphic 26)
NDC 66993-135-97 is the code for Fluticasone Furoate/Vilanterol ELLIPTA Inhalation Powder for oral inhalation only. It comes in an inhaler containing 30 doses and contains 2 foil strips of 30 blisters each. One strip contains 100 meg of fluticasone furoate and lactose monohydrate while the other strip contains 25 mcg of vilanterol, magnesium stearate, and lactose monohydrate. It is meant for prescription only.*
Fluticasone Furoate-vilanterol Ellipta 200mcg-25mcg Carton (Ff Vil Spl Graphic 27)
NDC 66993-136-97 is a prescription medication in the form of Fluticasone Furoate/Vilanterol ELLIPTA Inhalation Powder for oral inhalation. It contains two separate foil strips. One strip contains 30 blisters where each blister contains 200 mcg of fluticasone furoate and lactose monohydrate, while the other strip contains 30 blisters where each blister contains 25 mcg of vilanterol, magnesium stearate, and lactose monohydrate. Its package comes with an ELLIPTA inhaler containing 30 doses, 60 blisters in total.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
